Detalles de la búsqueda
1.
Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease.
N Engl J Med
; 373(20): 1937-46, 2015 Nov 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-26559572
2.
Optimal medical therapy with or without percutaneous coronary intervention in women with stable coronary disease: A pre-specified subset analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation (COURAGE) trial.
Am Heart J
; 173: 108-17, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26920603
3.
Prognostic importance of coronary anatomy and left ventricular ejection fraction despite optimal therapy: assessment of residual risk in the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation Trial.
Am Heart J
; 166(3): 481-7, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24016497
4.
Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention.
Am Heart J
; 164(2): 243-50, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22877811
5.
Comparison of Characteristics and Outcomes of Veterans With Stable Ischemic Heart Disease Enrolled in the COURAGE Trial Versus the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.
Am J Cardiol
; 180: 1-9, 2022 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35918234
6.
Effect of PCI on quality of life in patients with stable coronary disease.
N Engl J Med
; 359(7): 677-87, 2008 Aug 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-18703470
7.
Optimal medical therapy with or without PCI for stable coronary disease.
N Engl J Med
; 356(15): 1503-16, 2007 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-17387127
8.
Influence of LDL-Cholesterol Lowering on Cardiovascular Outcomes in Patients With Diabetes Mellitus Undergoing Coronary Revascularization.
J Am Coll Cardiol
; 76(19): 2197-2207, 2020 11 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33153578
9.
Risk Prediction Tool for Assessing the Probability of Death or Myocardial Infarction in Patients With Stable Coronary Artery Disease.
Am J Cardiol
; 130: 1-6, 2020 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32654755
10.
Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.
Circulation
; 117(10): 1283-91, 2008 Mar 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-18268144
11.
Lifestyle, Glycosylated Hemoglobin A1c, and Survival Among Patients With Stable Ischemic Heart Disease and Diabetes.
J Am Coll Cardiol
; 73(16): 2049-2058, 2019 04 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-31023428
12.
Effect of Coronary Anatomy and Myocardial Ischemia on Long-Term Survival in Patients with Stable Ischemic Heart Disease.
Circ Cardiovasc Qual Outcomes
; 12(2): e005079, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30773025
13.
Impact of treatment strategies on outcomes in patients with stable coronary artery disease and type 2 diabetes mellitus according to presenting angina severity: A pooled analysis of three federally-funded randomized trials.
Atherosclerosis
; 277: 186-194, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29861270
14.
Healthy Behavior, Risk Factor Control, and Survival in the COURAGE Trial.
J Am Coll Cardiol
; 72(19): 2297-2305, 2018 11 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30384885
15.
The evolving pattern of symptomatic coronary artery disease in the United States and Canada: baseline characteristics of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial.
Am J Cardiol
; 99(2): 208-12, 2007 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17223420
16.
Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial Veterans Affairs Cooperative Studies Program no. 424.
Am Heart J
; 151(6): 1173-9, 2006 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-16781214
17.
Medical Treatment and Revascularization Options in Patients With Type 2 Diabetes and Coronary Disease.
J Am Coll Cardiol
; 68(10): 985-95, 2016 09 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27585501
18.
Effect of baseline exercise capacity on outcomes in patients with stable coronary heart disease (a post hoc analysis of the clinical outcomes utilizing revascularization and aggressive drug evaluation trial).
Am J Cardiol
; 116(10): 1509-15, 2015 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26410604
19.
Validation of the appropriate use criteria for percutaneous coronary intervention in patients with stable coronary artery disease (from the COURAGE trial).
Am J Cardiol
; 116(2): 167-73, 2015 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25960375
20.
Predicting outcome in the COURAGE trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation): coronary anatomy versus ischemia.
JACC Cardiovasc Interv
; 7(2): 195-201, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24440015